Navigation Links
Frost & Sullivan Recognizes GenePOC's Growth Backed by Strong Leadership and Technology Excellence
Date:2/25/2013

nalysis and extensive secondary research to identify best practices in the industry.

About GenePOC, Inc.

Created in 2007 and located in Quebec city, Canada, GenePOC, Inc. is a privately owned company that develops rapid and cost-effective molecular tests to detect genes at Point of Care (POC).

Since the PCR has been invented in the mid 80's, GenePOC founder, Dr. Michel G. Bergeron , had the goal of using DNA to speed up the identification of microbes to one hour or less instead of more than 48 hours with standard culture. For more information visit http://www.genepoc-diagnostics.com/Home.shtml

GenePOC Contact: 


Dr. Patrice Allibert , Ph.D., CEO,
P: +1 418 570 3611
E: patrice.allibert@genepoc.ca
www.genepoc-diagnostics.com

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includ
    '/>"/>

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Frost & Sullivan Accolade for Swissrays Exceptional Dedication to its Customers
2. Novel Biomaterials Accelerate the Development of Innovative Wound Care Management Technologies, Finds Frost & Sullivan
3. Frost & Sullivan: Clinical Trial-based Evidence Vital to Obtain Venture Capital Funding for Wireless Patient Monitoring Technologies
4. Frost & Sullivan Acknowledges that PKCs Biosensors are Expected to Become the New Industry Standard in Pathogen Testing
5. Increasing Surgical Volumes to Boost Use of Tissue Sealants and Topical Haemostats, Says Frost & Sullivan
6. Frost & Sullivan: Digitisation of Australias healthcare system met with widespread apprehension
7. Frost & Sullivan Recognizes ResearchDx for Its Impressive Performance in the Companion Diagnostics Sector
8. Gains from a Growing Patient Pool for Cardiac Rhythm Management Devices Offset by Lower Product Pricing, Observes Frost & Sullivan
9. Frost & Sullivan Determines a Real and Urgent Need for Novel Cancer Diagnostics Tests
10. Best Practices Involving Product Innovation and Creation of Value Vital for Customer Retention, Finds Frost & Sullivan
11. Contract Research Organisations offer Promise of Innovative, Safe and Effective Drug Development, Says Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... November 26, 2014 Investor-Edge has initiated ... VVUS ), Horizon Pharma PLC (NASDAQ: HZNP ), ... (NYSE: JNJ ), and Theravance Inc. (NASDAQ: ... be accessed at: http://investor-edge.com/register . On Tuesday, ... 0.07%, the Dow Jones Industrial Average edged 0.02% lower, to ...
(Date:11/26/2014)... , Nov. 26, 2014  CARsgen, a leader in ... immunotherapy to treat a variety of cancers, today announced ... BVCF, a China -based healthcare private ... company focused on the development of new therapeutics for ... Shanghai Cancer Institute and Shanghai Renji Hospital, the company ...
(Date:11/26/2014)... -- At the American Dental Association,s Annual Meeting in ... Group was honored to be part of the 2014 ... see and test the Best of Class winners and ... the latest developments in dental technology. This year, featured ... Caries Detection Device and Kerr Demi ™  Ultra ...
Breaking Medicine Technology:Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5CARsgen Completes Series A Financing 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3
... Aug. 4 Tolerx, Inc. , a ... and cancer by modulating T cell activity, today announced ... Ph.D., as Chief Scientific Officer. Dr. de Fougerolles’ appointment ... research and early-stage product development programs involving novel therapies ...
... Healthcare, Inc. (Nasdaq: GRMH ) will host a conference ... , to discuss the company,s financial results for Q2, 2010. Management will review ... , , , ... be webcast on the investor relations section of Graymark,s website at http://www.graymarkhealthcare.com ...
Cached Medicine Technology:Tolerx Appoints Antonin de Fougerolles, Ph.D., as Chief Scientific Officer 2Tolerx Appoints Antonin de Fougerolles, Ph.D., as Chief Scientific Officer 3Tolerx Appoints Antonin de Fougerolles, Ph.D., as Chief Scientific Officer 4Graymark Healthcare, Inc. to Host Conference Call to Discuss Q2 Financial Results 2
(Date:11/26/2014)... 26, 2014 With a redesign of ... Steven Meier has enhanced the user experience and ... prospective patients an online destination for orthopedic and sports ... present the new and improved version of the website. ... easier than ever for current and prospective patients to ...
(Date:11/26/2014)... ISI Telemanagement Solutions, Inc., a leading ... the 2014 Lync Pioneer Award by ... a great honor to ISI, who continues to ... ISI offers an integrated collaboration reporting and recording ... voice, video, Lync IM, and conferencing. , ...
(Date:11/26/2014)... For those with a New Year’s resolution to get in ... at the University of Colorado Anschutz Health and Wellness Center ... 45- 60 minute classes have just started and are included ... memberships. , LES MILLS BODYPUMP™ exercise classes strengthen, condition and ... fast results , By focusing on low weight loads ...
(Date:11/26/2014)... Youngsters who enter puberty early are at increased risk ... was linked with a number of factors associated with ... according to the researchers. Early puberty was also linked ... peers, and having friends who were prone to getting ... found an association between early puberty and these factors, ...
(Date:11/26/2014)... HealthDay Reporter TUESDAY, Nov. 25, 2014 (HealthDay ... and Drug Administration will have many restaurant chains posting calorie ... movie theater popcorn and ice cream parlor fare. "Americans ... often consuming less nutritious food and underestimating the calories they ... afternoon news conference. Although listing calorie counts on ...
Breaking Medicine News(10 mins):Health News:Los Angeles Orthopedic Surgeon Dr. Steven Meier Announces Relaunch Of Practice Website 2Health News:ISI Telemanagement Solutions, Inc. has been Awarded the 2014 Microsoft Lync Pioneer Award 2Health News:LES MILLS BODYPUMP™ classes come to the University of Colorado Anschutz Health and Wellness Center 2Health News:Early Puberty Linked to Increased Risk of Depression in Teens 2Health News:Calorie Counts Mandated at Chain Restaurants, FDA Says 2Health News:Calorie Counts Mandated at Chain Restaurants, FDA Says 3
... , MONDAY, March 28 (HealthDay News) -- Teenagers ... likely to start using marijuana by the time they,re 17, ... birth cohort study that began in 1994 found that by ... and 12 percent of boys had used marijuana or other ...
... San Diego School of Medicine claim that the availability of ... that surgery should become an important part of the primary ... C. Chang, PhD, MPH, MBA, director of Outcomes Research in ... out that surgery in the United States continues to be ...
... ANN ARBOR, Mich. Most women face only a small ... treatment. Yet a new study from the University of Michigan ... speak little English expressed a great deal of worry about ... for some women, these worries can be so strong that ...
... recognizes and neutralizes or destroys toxins and foreign pathogens ... result when the system attacks the body,s own tissues ... sclerosis (MS). MS is a serious condition in which ... spinal cord are destroyed as a result of misdirected ...
... , SUNDAY, March 27 (HealthDay News) -- Baseball ... finds a new study. Researchers analyzed data from more ... and found that pitchers whose teammates were hit by a ... the temperature reached 90 degrees F than on cooler days. ...
... study published today provides a new perspective on the Great ... there were remarkable improvements in life expectancy of over five ... was actually associated with an increase in suicides but reduction ... the current recession in Europe and the U.S. The study, ...
Cached Medicine News:Health News:Surgeon availability tied to survival rate in vehicle crashes 2Health News:Some women worry too much about breast cancer returning, U-M study finds 2Health News:A possible new target for treatment of multiple sclerosis 2Health News:A possible new target for treatment of multiple sclerosis 3Health News:Great Depression did not significantly improve life expectancy in the US 2
... Single Use reloadable linear stapler with ... PI™ disposable stapler is designed for use ... healthy internal tissues. The instrument places a ... when using the 30 VASCULAR cartridges) of ...
... Single Use Loading Units With ... ILA™ 75 (Single Use Reloadable ... ,INDICATIONS The ILA™ 75 single-use ... for use in the resection, ...
... 75 single-use stapler, anastomotic type, is ... transection, and/or the anastomosis of normal, ... ILA™ 75 single-use stapler, anastomotic type, ... resection, transection, and/or the anastomosis of ...
... The PROXIMATE HCS Procedure for Prolapse and ... of titanium staples in 33mm diameter size. ... canal for transection and resection of internal ... surgical treatment of hemorrhoidal disease. The PPH01 ...
Medicine Products: